UAE Completes Trial for Russian Coronavirus Vaccine

Trials of Russia’s adenovirus-based vaccine in the United Arab Emirates have completed the inoculation phase, the Abu Dhabi government said.

Testing will move into the scientific data collection phase after 1,000 volunteers in the UAE received a second dose and the next step involves monitoring volunteers’ immune response over 180 days. UAE results will be combined with existing findings elsewhere. Interim results will be released in April.

The Lancet medical journal confirmed Sputnik V’s efficacy in peer-reviewed findings in February, showing an efficacy of 91.6%. The UAE conducted clinical trials of the shot on more than 1,000 volunteers. It’s also collaborating with the Russian Direct Investment Fund to test a combination of AstraZeneca and Sputnik V vaccines.

©2021 Bloomberg L.P.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.